by Clinical Neuropsychologist | Thursday, January 22, 2026 | Neuroimaging
ABSTRACT Background and Purpose Embolic stroke of undetermined source (ESUS) may be associated with carotid artery plaques with <50% stenosis. Plaque vulnerability is multifactorial, possibly related to intraplaque hemorrhage (IPH), lipid-rich necrotic core,...
by Clinical Neuropsychologist | Saturday, January 17, 2026 | Neuroimaging
ABSTRACT Background and Purpose Chimeric antigen receptor–engineered T-cell (CAR-T) therapy in hematological malignancies may be associated with severe complications, as Cytokine Release Syndrome (CRS) and Immune effector Cell-Associated Neurotoxicity Syndrome...
by Clinical Neuropsychologist | Friday, December 19, 2025 | Neuroimaging
ABSTRACT Background and Purpose Diffusion-weighted imaging (DWI) is the gold standard for assessing ischemic core in acute stroke but may overestimate irreversible injury due to its assumption of Gaussian diffusion. Diffusion kurtosis imaging (DKI), which accounts for...
by Clinical Neuropsychologist | Wednesday, December 17, 2025 | Neuroimaging
ABSTRACT Background and Purpose Amygdala dysfunction is implicated in major depressive disorder. Despite wide acknowledgement of its heterogeneity, the amygdala is predominantly considered as a single entity and functional connectivity investigations have reported...
by Clinical Neuropsychologist | Monday, December 1, 2025 | Neuroimaging
ABSTRACT Background and Purpose Neuromelanin-sensitive magnetic resonance imaging (NM-MRI) is an emerging noninvasive biomarker of catecholaminergic neurons. It assesses neuromelanin-rich regions such as the substantia nigra pars compacta (SNc) and locus coeruleus...
